http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2369333-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cffd21fb0321624ede92387644164cd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fae245f3de0f7241d6fc08cce59f7af8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b47e3e05f88d9cffadea80bfde670a70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_623e5683e1732c4048ddd1bdc266a3d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcb0c2e2d13dd74c9e98b25054d16945
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fabfcd6a35989828410ea2a5e365ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b4cebdd527f692d36c3bb4c0222276a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00
filingDate 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde8ffa4ad35c91e699f8d0b04a5a009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48217b144edd4c47296b4e541d17eccc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8601dc8592715ad1b9cea8a014772b70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f09c42cb861d714fb8696fdb83e8d5f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9fb0a00ecdf07ef3ebfd5bd7054d0a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d36ca8067ad5da28de3a9bcaf7386e37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dca2b28c33647d39be446308a519607
publicationDate 2009-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2369333-C2
titleOfInvention Method of detemining dyskinesis of bile bladder and oddi's sphincter
abstract FIELD: medicine. n SUBSTANCE: invention relates to field of medicine, namely to gastroenterology. In order to detect dyskinesis of bile bladder and Oddi's sphincter duodenal probe is performed. If duration of bubble bile stage is 30 min and less, strain of bile excretion is 2.3 ml/min and higher and if biochemical bile indices are: bilirubin 2.5-3.3 mmole/l, phospholipid-cholesterol coefficient is 0.41-0.51, cholate-cholesterol coefficient is 4.2-5.1, bile bladder and Oddi's sphincter dyskinesis is estimated as hyperkinetic. If duration of bubble bile stage is 40 min and longer, strain of bile excretion is 1.9 ml/min and less and if biochemical bile indices are: bilirubin 4.2-4.9 mmole/l, phospholipid-cholesterol coefficient is 0.14-0.27, cholate-cholesterol coefficient is 2.1-2.7, bile bladder and Oddi's sphincter dyskinesis is estimated as hypokinetic. n EFFECT: increasing accuracy of determining bile bladder and Oddi's sphincter dyskinesis. n 4 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2676965-C1
priorityDate 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588349

Total number of triples: 31.